These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 8540495)

  • 1. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites.
    Guardiola J; Baliellas C; Xiol X; Fernandez Esparrach G; Ginès P; Ventura P; Vazquez S
    Am J Gastroenterol; 2002 Sep; 97(9):2374-8. PubMed ID: 12358259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.
    Salerno F; Borroni G; Moser P; Badalamenti S; Cassarà L; Maggi A; Fusini M; Cesana B
    Am J Gastroenterol; 1993 Apr; 88(4):514-9. PubMed ID: 8470631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of the effects of a peritoneo-venous shunt and of concentration-reinfusion on the survival of cirrhotic subjects with "intractable" ascites].
    Torre GC; Testa R
    Minerva Med; 1982 Jun; 73(27):1871-5. PubMed ID: 7088400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S; Labianca M; Smadja C; Grange D; Franco D
    Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor outcome from peritoneovenous shunts for refractory ascites.
    Scholz DG; Nagorney DM; Lindor KD
    Am J Gastroenterol; 1989 May; 84(5):540-3. PubMed ID: 2719011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure.
    Hillaire S; Labianca M; Borgonovo G; Smadja C; Grange D; Franco D
    Surgery; 1993 Apr; 113(4):373-9. PubMed ID: 8456392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney.
    Hamel B; Guillaud O; Roman S; Vallin M; Pilleul F; Valette PJ; Henry L; Guibal A; Mion F; Dumortier J
    Dig Liver Dis; 2014 Nov; 46(11):1001-7. PubMed ID: 25096966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of patients hospitalized for management of cirrhotic ascites.
    Planas R; Montoliu S; Ballesté B; Rivera M; Miquel M; Masnou H; Galeras JA; Giménez MD; Santos J; Cirera I; Morillas RM; Coll S; Solà R
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1385-94. PubMed ID: 17081806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
    Borie DC; Vaillant JC; Breton S; Hannoun L
    Ann Chir; 1999; 53(10):966-72. PubMed ID: 10670142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
    Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC
    Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
    Kreuzer W
    Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term results of the peritoneovenous shunt in the treatment of intractable ascites in cirrhotic patients].
    Dellepiane M; Capussotti L; Polastri R; Mensa G; Marucci MM; Fusario F
    Minerva Med; 1987 May; 78(10):717-20. PubMed ID: 3587721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.